Guardant Health, Inc. (GH)
GH price $166.66 +4.07 +2.50%
- Ticker
- GH
- Price
- $166.66
- Change
- +4.07 +2.50%
- Market cap
- $22.37B
- P/E
- -47.75
- Forward P/E
- 189.52
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 51
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and…